Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema

American Journal of Respiratory and Critical Care Medicine

Volumn 153, Issue 1, 1996, Pages 176-184

  Günther, Andreas ^a   Siebert, Carsten ^a   Schmidt, Reinhold ^a   Ziegler, Stefanie ^a   Grimminger, Friedrich ^a   Yabut, Marife ^a   Temmesfeld, Bettina ^a   Walmrath, Dieter ^a   Morr, Harald ^a   Seeger, Werner ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LUNG SURFACTANT; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLGLYCEROL; PHOSPHATIDYLINOSITOL; PHOSPHOLIPID; PROTEIN; SPHINGOMYELIN;

ADOLESCENT; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; HUMAN; LIPID COMPOSITION; LUNG EDEMA; LUNG INJURY; LUNG LAVAGE; MAJOR CLINICAL STUDY; PNEUMONIA; PRIORITY JOURNAL; PROTEIN ANALYSIS;

EID: 8944263464     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.153.1.8542113     Document Type: Article

References (42)

1. Hallman, M., R. Spragg, J. H. Harrell, K. M. Moser, and L. Gluck. 1982. Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol. J. Clin. Invest. 70:673-683.
2. Pison, U., W. Seeger, R. Buchhorn, T. Joka, M. Brand, U. Obertacke, H. Neuhof, and K. Schmit-Neuerburg. 1989. Surfactant abnormalities in patients with respiratory failure after multiple trauma. Am. Rev. Respir. Dis. 140:1033-1039.
3. Gregory, T. J., W. J. Longmore, M. A. Moxley, J. A. Whitsett, C. R. Reed, A. A. Fowler, III, L. D. Hudson, R. J. Maunder, C. Crim, and T. M. Hyers. 1991. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J. Clin. Invest. 88:1976-1981.
4. Lewis, J. F., and A. H. Jobe. 1993. Surfactant and the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 147:218-233.
5. Seeger, W., A. Günther, H. D. Walmrath, F. Grimminger, and H. G. Lasch. 1993. Alveolar surfactant and adult respiratory distress syndrome. Pathogenetic role and therapeutic prospects. Clinical Investigator 71:177-190.
6. Bernard, G. R., A. Artigas, K. L. Brigham, J. Carlet, K. Falke, L. Hudson, M. Lamy, J. R. Legall, A. Morris, R. Spragg, and the Consensus Committee. 1994. The American-European Consensus Conference on ARDS. Am. J. Respir. Crit. Care Med. 149:818-824.
7. Sloane, P. J., M. H. Gee, J. E. Gottlieb, K. H. Albertine, S. P. Peters, J. R. Burns, G. Maciedo, and J. E. Fish. 1992. A multicenter registry of patients with acute respiratory distress syndrome. Am. Rev. Respir. Dis. 146:419-426.
8. Seidenfeld, J. J., D. F. Pohl, R. C. Bell, G. D. Harris, and W. G. Johanson. 1986. Incidence, site, and outcome of infections in patients with the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 134:12-16.
9. Honda, Y., H. Takahashi, N. Shijubo, Y. Kuroki, and T. Akino. 1993. Surfactant protein-A concentration in bronchoalveolar lavage fluids of patients with pulmonary alveolar proteinosis. Chest 103:496-499.
10. Fujita, Y., K. Kogishi, and Y. Suzuki. 1988. Pulmonary damage induced in mice by a monoclonal antibody to proteins associated with pig pulmonary surfactant. Exp. Lung Res. 14:247-260.
11. Warr, R. G., S. Hawgood, D. I. Buchley, T. M. Crisp, J. Schilling, B. J. Benson, P. L. Ballard, J. A. Clements, and R. T. White. 1987. Low-molecular-weight human pulmonary surfactant (sps): isolation, characterization and cDNA and amino sequences. Proc. Natl. Acad. Sci. U.S.A. 84:7915-7919.
12. Fraser, R. G. (editor), J. A. P. Paré, P. D. Paré, R. S. Fraser, and G. P. Genereux. 1989. Diagnosis of Diseases of the Chest, 3rd ed. W. B. Saunders Company, Philadelphia.
13. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. 37:911-917.
14. Rouser, G., S. Fleischer, and A. Yamamoto. 1969. Two dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids 5: 494-496.
15. Rennard, S. L., G. Basset, D. Lecossier, K. M. O'Donnell, P. Pinkston, P. G. Martin, and R. G. Crystal. 1986. Estimation of epithelial lining fluid recovered by lavage using urea as a marker for dilution. J. Appl. Physiol. 60:532-538.
16. Smith, P. K., R. I. Krohn, G. T. Hermannson, A. K. Mallia, F. H. Gartner, M. D. Provenzano, E. K. Fujimoto, N. M. Goeke, B. J. Olson, and D. C. Klenk. 1985. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150:76-85.
17. Gustavsson, L. 1986. Densitometric quantification of individual phospholipids. J. Chromatogr. 395:255-266.
18. Krämer, H.-J., R. Schmidt, A. Günther, Y. Suzuki, and W. Seeger. 1995. Quantification of surfactant-protein B by enzyme-linked immunosorbent assay (ELISA). Am. J. Respir. Crit. Care Med. (In press)
19. Enhorning, G. 1977. Pulsating bubble technique for evaluating pulmonary surfactant. J. Appl. Physiol. 43:198-203.
20. Bachofen, H., S. Schürch, M. Urbinelli, and E. R. Weibel. 1987. Relations among alveolar surface tension, surface area, volume, and recoil pressure. J. Appl. Physiol. 62:1878-1887.
21. Goerke, J., and J. A. Clements. 1986. Alveolar surface tension and lung surfactant. In P. T. Macklem and J. Medds, editors. Handbook of Physiology. The Respiratory System. Control of Breathing. American Physiological Society, Bethesda, MD. Sect. 3, Vol. II, Part 1, Ch. 9. 247-261.
22. von Wiehert, P., K. Joseph, B. Müller, and W. M. Franck. 1993. Bronchoalveolar lavage. Quantification of intraalveolar fluid. Am. Rev. Respir. Dis. 147:148-152.
23. Effros, R. M., C. Murphy, K. Ozker, and A. Hacker. 1992. Kinetics of urea exchange in air-filled and fluid-filled rat lungs. Am. J. Physiol. 263:L619-L626.
24. Hallman, M., P. Maasilta, L. Kivisaari, and K. Mattson. 1990. Changes in surfactant in bronchoalveolar lavage fluid after hemithorax irradiation in patients with mesothelioma. Am. Rev. Respir. Dis. 141: 998-1005.
25. Baughman, R. P., R. I. Sternberg, W. Hull, J. A. Buchsbaum, and J. Whitsett. 1993. Decreased surfactant protein A in patients with bacterial pneumonia. Am. Rev. Respir. Dis. 147:653-657.
26. Hofmann, A. G. D., M. G. Lawrence, F. P. Ognibene, A. F. Suffredini, G. Y. Lipschik, J. A. Kovacs, H. Masur, and J. H. Shelhamer. 1992. Reduction of pulmonary surfactant in patients with human immunodeficiency virus infection and Pneumocystis carinii pneumonia. Chest 102:1730-1738.
27. Escamilla, R., M.-C. Prevost, C. Cariven, C. Hermant, M. Krempf, and H. Chap. 1993. Bronchoalveolar lavage phospholipid abnormalities in HIV-infected patients. Eur. Respir. J. 6:1301-1307.
28. Gross, N. J., and K. R. Karine. 1989. Surfactant subtypes in mice: characterization and quantification. J. Appl. Physiol. 66:342-349.
29. Ueda, T., M. Ikegami, and A. Jobe. 1994. Surfactant subtypes, in vitro conversion, in vivo function, and effects of serum proteins. Am. J. Respir. Crit. Care Med. 149:1254-1259.
30. Veldhuizen, R. A. W., S. A. Hearn, J. F. Lewis, and F. Possmayer. Surface-area cycling of different surfactant preparations: SP-A and SP-B are essential for large-aggregate integrity. Biochem. J. 300: 519-524.
31. Lewis, J., M. Ikegami, and A. Jobe. 1990. Altered surfactant function and metabolism in rabbits with acute lung injury. J. Appl. Physiol. 69:2303-2310.
32. van Golde, L. M. G., J. J. Batenburg, and B. Robertson. 1988. The pulmonary surfactant system: Biochemical aspects and functional significance. Physiol. Rev. 68:374-455.
33. Pison, U., U. Obertacke, W. Seeger, and S. Hawgood. 1992. Surfactant protein A (SP-A) is decreased in acute parenchymal lung injury associated with polytrauma. Eur. J. Clin. Invest. 22:712-718.
34. Seeger, W., A. Günther, and C. Thede. 1992. Differential sensitivity to fibrinogen inhibition of SP-C- vs. SP-B-based surfactants. Am. J. Physiol. 261:L286-L291.
35. Holm, B. A., G. Enhorning, and R. H. Notter. 1988. A biophysical mechanism by which plasma proteins inhibit lung surfactant activity. Chem. Phys. Lipids 49:49-55.
36. Venkitaraman, A. R., J. E. Baatz, J. A. Whitsett, S. B. Hall, and R. H. Notter. 1991. Biophysical inhibition of synthetic phospholipid-lung surfactant apoprotein admixtures by plasma proteins. Chem. Phys. Lipids 57:49-57.
37. Seeger, W., A. Elssner, A. Günther, H.-J. Krämer, and H. O. Kalinowski. 1993. Lung surfactant phospholipids associate with polymerizing fibrin: loss of surface activity. Am. J. Respir. Cell Mol. Biol. 9:213-220.
38. Hallman, M. 1991. Lung surfactant in respiratory distress syndrome. Acta Anaesthesiol. Scand. 35(Suppl. 95): 15-21.
39. Holm, B. A., L. Keicher, J. Sokolowski, and G. Enhorning. 1991. Inhibition of pulmonary surfactant function by phospholipases. J. Appl. Physiol. 71:317-321.
40. Pison, U., E. K. Tam, G. H. Caughey, and S. Hawgood. 1989. Proteolytic inactivation of dog lung surfactant-associated proteins by neutrophile elaslase. Biochim. Biophys. Acta 992:251-257.
41. Seeger, W., H. Lepper, H. R. D. Wolf, and H. Neuhof. 1985. Alteration of surfactant function after exposure to oxidative stress and to oxygenated and native arachidonic acid in vitro. Biochim. Biophys. Acta 835:58-67.
42. van Daal, G. J., J. A. H. Bos, E. P. Eijking, D. Gommers, E. Hannappel, and B. Lachman. 1992. Surfactant replacement therapy improves pulmonary mechanics in end-stage influenza A pneumonia in mice. Am. Rev. Respir. Dis. 145:859-863.